CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS

摘要

The invention encompasses compounds of formula (I) as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.